Compound Detail
CHEMBL311500
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL311500 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ACTLZZFXDVWKTJ-UHFFFAOYSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
343.4
MW (Da)
-0.12
ALogP
9
HBA
3
HBD
134.5
PSA (Ų)
0.58
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 3 meas. best 6.0
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | EC50 | = | 1000.0 | nM | 6.0 | In vitro concentration required to inhibit HBV DNA secretion by HepG2.2.15 trans... | 12852943 |
| ADMET | EC50 | = | 10000.0 | nM | 5.0 | In vitro concentration required to inhibit the HIV-1 LA1 replication on PBMCs ce... | 12852943 |
| MT4 | EC50 | = | 15000.0 | nM | 4.82 | In vitro concentration required to inhibit the cytopathicity of HIV-1 IIIB on MT... | 12852943 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 12852943 | 10.1016/s0960-894x(03)00496-7 | MT4 | 2 |
| 12852943 | 10.1016/s0960-894x(03)00496-7 | Unchecked | 2 |
| 12852943 | 10.1016/s0960-894x(03)00496-7 | ADMET | 2 |
| 12852943 | 10.1016/s0960-894x(03)00496-7 | HepG2 | 1 |
Data from ChEMBL 36 via Core Engine